tiprankstipranks
Novabay Pharmaceuticals (NBY)
XASE:NBY
US Market
NBY
NovaBay Pharma
RESEARCH TOOLSreports

NovaBay Pharma (NBY) Income Statement

804 Followers

NovaBay Pharma Income Statement

Last quarter (Q4 2025), NovaBay Pharma's total revenue was $-521.00K, a decrease of -122.56% from the same quarter last year. In Q4, NovaBay Pharma's net income was $-26.60M. See NovaBay Pharma’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 25Dec 24Dec 23Dec 22Dec 21
Total Revenue
$ 0.00$ 9.78M$ 10.46M$ 14.40M$ 10.20M
Gross Profit
$ -140.00K$ 6.48M$ 6.08M$ 7.78M$ 6.51M
Operating Expenses
$ 7.45M$ 12.32M$ 10.19M$ 22.20M$ 15.38M
Depreciation and Amortization
$ 140.00K$ 381.00K$ 356.00K$ 483.00K$ 119.00K
EBITDA
$ -7.45M$ -5.92M$ -4.09M$ -7.20M$ -8.74M
Operating Income
$ -7.58M$ -5.84M$ -4.10M$ -14.42M$ -8.86M
Other Income/Expenses
$ -25.64M$ -1.37M$ -2.04M$ 3.81M$ 3.04M
Pretax Income
$ -33.22M$ -7.21M$ -6.14M$ -10.61M$ -5.82M
Net Income
$ -22.14M$ -7.22M$ -9.64M$ -10.61M$ -5.82M
Per Share Metrics
Basic EPS
$ -3.80$ -0.51$ -27.83$ -70.72$ -36.82
Diluted EPS
$ -3.80$ -0.51$ -27.73$ -70.72$ -36.82
Weighted Average Shares Outstanding
 5.82M 16.98M 600.00K 150.00K 158.18K
Weighted Average Shares Outstanding (Diluted)
 5.82M 16.98M 600.00K 230.00K 178.15K
Currency in USD

NovaBay Pharma Earnings and Revenue History